Royal Bank of Canada
LLY icon

Royal Bank of Canada’s Eli Lilly LLY Stock Holding History

Royal Bank of Canada’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$736K Sell
800
-149,600
-99% -$152M ﹤0.01% 3853
2025
Q4 		$162M Buy
150,400
+150,200
+75,100% +$144M 0.03% 489
2025
Q3 		$153K Hold
200
– – ﹤0.01% 5249
2025
Q2 		$156K Buy
+200
New +$155K ﹤0.01% 5328
2020
Q2 		– Sell
-285,000
Closed -$39.5M – 6771
2020
Q1 		$39.5M Buy
+285,000
New +$39.2M 0.02% 581
2019
Q3 		– Sell
-1,000
Closed -$111K – 6923
2019
Q2 		$111K Buy
1,000
+800
+400% +$94.2K ﹤0.01% 4813
2019
Q1 		$26K Buy
+200
New +$24.3K ﹤0.01% 5523
2018
Q2 		– Sell
-100,000
Closed -$7.74M – 6662
2018
Q1 		$7.74M Sell
100,000
-76,300
-43% -$6.14M ﹤0.01% 1707
2017
Q4 		$14.9M Buy
176,300
+4,600
+3% +$391K 0.01% 1329
2017
Q3 		$14.7M Sell
171,700
-67,800
-28% -$5.56M 0.01% 1290
2017
Q2 		$19.7M Buy
239,500
+42,200
+21% +$3.44M 0.01% 1067
2017
Q1 		$16.6M Sell
197,300
-253,400
-56% -$20.3M 0.01% 1149
2016
Q4 		$33.1M Sell
450,700
-213,600
-32% -$15.9M 0.02% 738
2016
Q3 		$53.3M Buy
664,300
+75,800
+13% +$6.07M 0.03% 482
2016
Q2 		$46.3M Buy
588,500
+341,300
+138% +$25.7M 0.03% 505
2016
Q1 		$17.8M Sell
247,200
-9,100
-4% -$689K 0.01% 997
2015
Q4 		$21.6M Buy
256,300
+247,300
+2,748% +$20.5M 0.01% 910
2015
Q3 		$753K Sell
9,000
-72,500
-89% -$6.12M ﹤0.01% 3119
2015
Q2 		$6.8M Buy
+81,500
New +$6.21M ﹤0.01% 1419
2015
Q1 		– Sell
-600
Closed -$41K – 6286
2014
Q4 		$41K Buy
+600
New +$40.5K ﹤0.01% 5137
2014
Q2 		– Sell
-7,500
Closed -$441K – 6049
2014
Q1 		$441K Buy
7,500
+7,300
+3,650% +$407K ﹤0.01% 3442
2013
Q4 		$10K Hold
200
– – ﹤0.01% 5452
2013
Q3 		$10K Hold
200
– – ﹤0.01% 5412
2013
Q2 		$10K Buy
+200
New +$10.9K ﹤0.01% 5281

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royal Bank of Canada's LLY Position: Q1 2026 in Review

Royal Bank of Canada reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $109M and leaving 4,262,531 shares worth $3.92B. The position accounts for 0.69% of the portfolio, ranked #26.

Royal Bank of Canada first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.7B in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Royal Bank of Canada held 4,262,531 shares of Eli Lilly worth $3.92B as of Q1 2026.
  • Royal Bank of Canada sold 107,202 Eli Lilly shares in Q1 2026, an estimated $109M.
  • Eli Lilly made up 0.69% of Royal Bank of Canada's portfolio in Q1 2026, its #26 holding.
  • Royal Bank of Canada first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Eli Lilly position peaked at $4.7B in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.